ArticleStructural chemistry2022

Hybrid drug-screening strategy identifies potential SARS-CoV-2 cell-entry inhibitors targeting human transmembrane serine protease.

Yufei Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.